Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Treasury Shares: 2009-2025

Historic Treasury Shares for Prestige Consumer Healthcare (PBH) over the last 15 years, with Mar 2025 value amounting to $277.2 million.

  • Prestige Consumer Healthcare's Treasury Shares rose 48.85% to $392.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $392.2 million, marking a year-over-year increase of 48.85%. This contributed to the annual value of $277.2 million for FY2025, which is 26.22% up from last year.
  • According to the latest figures from FY2025, Prestige Consumer Healthcare's Treasury Shares is $277.2 million, which was up 26.22% from $219.6 million recorded in FY2024.
  • Prestige Consumer Healthcare's 5-year Treasury Shares high stood at $6.5 million for FY2025, and its period low was $4.1 million during FY2021.
  • Moreover, its 3-year median value for Treasury Shares was $5.7 million (2024), whereas its average is $5.8 million.
  • Data for Prestige Consumer Healthcare's Treasury Shares shows a peak YoY skyrocketed of 41.50% (in 2023) over the last 5 years.
  • Yearly analysis of 5 years shows Prestige Consumer Healthcare's Treasury Shares stood at $130.7 million in 2021, then climbed by 2.23% to $133.6 million in 2022, then skyrocketed by 41.50% to $189.1 million in 2023, then rose by 16.13% to $219.6 million in 2024, then climbed by 26.22% to $277.2 million in 2025.